Granulocyte function disorders: aspects of development, genetics and management.
The field of phagocytic disorders has attained major biologic and clinical significance in the past 40 years. The development of exciting new techniques in molecular biology and the cellular physiology of signal transduction have made it possible to identify the genetic defects involved in many of these disorders. Moreover through immunopharmacologic intervention, bone marrow or peripheral or cord blood stem cell transplantation along with the prospect of gene therapy, we have begun attempts to at least partially correct genetic defects in cell development and activation pathways in the entire spectrum of phagocyte disorders. Carrier detection and prenatal diagnosis employing with chain reaction techniques or direct nucleotide sequencing in fetal blood have made these diseases potentially preventable or treatable in utero or shortly after birth.
Yang
K D
KD
Chang Gung Children's Hospital at Kaohsiung, Chang Gung University, Kaohsiung 833, Taiwan.
Hill
H R
HR
D000380:Agranulocytosis / Q000151:congenital / Q000235:genetics* / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D015316:Genetic Therapy / Q000379:methods; D006098:Granulocytes / Q000502:physiology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008967:Molecular Biology; D010585:Phagocyte Bactericidal Dysfunction / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D010587:Phagocytosis / Q000235:genetics*; D011379:Prognosis